Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Nada Inc.
United States
- Dallas, Texas
- 27/07/2022
- Seed
- $8,100,000
Nada is democratizing the $23 trillion home equity market by reimagining the complicated transactional ownership model, fractionalizing homeowner equity and allowing anyone to invest in real estate for as little as $250. Its platform is the first to offer banking, investing, and financial services built for real estate. Consumers can fund their Nada Visa debit card with home equity, invest in the top cities, and trade shares in real estate funds all on one platform. Delivering innovation through financial products and technology since 2019, Nada is backed by Capital Factory Ventures, Insight Capital, VM Ventures, and The University of Texas at Austin.
- Industry Financial Services
- Website https://www.nada.co/
- LinkedIn https://www.linkedin.com/company/hellonada/
Related People
John R GreenCo Founder
United States -
Dallas, Texas
Co-founder & CEO @ Nada.co
John Green is a co-founder of Nada, where he has served as CEO since its inception. In addition, Mr. Green is a Managing Partner of Cityfunds.
Prior to his role as CEO of Nada, Mr. Green spent 10+ years in the mortgage industry where he led teams for Strategy & Innovation, and Risk & Quality. Prior to his career in financial services, Mr. Green was a professional recording and touring artist where he published two albums.
Mr. Green has been a member of the American Society of Composers, Authors, and Publishers since 2006. Mr. Green is also an active and published member of the Forbes Finance Council.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)